Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes. Embrex® Vaccine Manual Inovoject® (VMI) is the latest addition to ...
NEW YORK & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) has agreed to acquire Embrex, Inc. (NASDAQ: EMBX), an international agricultural ...
Pfizer Animal Health gains rights to Embrex’ In Ovo Poultry Vaccine-Delivery Technology Pfizer Animal Health agreed to acquire Embrex for an aggregate equity purchase price of approximately $155 ...
Agricultural biotechnology company Embrex is set to supply Perdigao, the second largest broiler chicken producer in Brazil, with cutting edge in ovo (in the egg) technology designed to cut production ...
Pfizer Animal Health has developed a new, compact version of its Inovoject device, used to inject vaccines direct into fertile eggs. “There has been a need for a smaller Inovoject for some time,” said ...
SAN FRANCISCO (MarketWatch) -- Embrex Inc. on Monday said the Department of Agriculture has granted its Inovocox coccidiosis vaccine for poultry a veterinary biological product license which allows it ...
Embrex, which provides inoculations for poultry against various diseases, is being sold. Pfizer Animal health, a division of health giant Pfizer, said Wednesday morning it would acquire Embrex for $17 ...
SAN FRANCISCO (MarketWatch) -- Drug stocks finished Wednesday higher, with shares of Embrex Inc. surging 40% after the company agreed to be acquired by No. 1 drug maker Pfizer Inc. for $155 million.
NEW YORK, Nov. 15 (UPI) -- U.S. firm Pfizer said Wednesday it had entered into a deal to acquire the U.S.-based agricultural biotech company Embrex for $155 million. Pfizer, which hopes the move will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results